Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Psycho-Oncology

Lynne I. Wagner

琳恩·瓦格纳

PhD

🏢Wake Forest University School of Medicine(维克森林大学医学院)🌐USA

Professor of Social Sciences and Health Policy; Director, Oncology Patient-Reported Outcomes Program社会科学与健康政策教授;肿瘤患者报告结局项目主任

44
h-index
3
Key Papers
3
Awards
3
Key Contributions

👥Biography 个人简介

Dr. Wagner is a leading expert on patient-reported outcomes (PROs) in oncology, directing research that integrates PRO measurement into clinical trials and practice. Her work on symptom burden, cognitive impairment, and emotional well-being has informed FDA guidance on PRO endpoints in cancer drug development.

Share:

🧪Research Fields 研究领域

Patient-Reported Outcomes患者报告结局
Symptom Management症状管理
Psycho-Oncology心理肿瘤学
Cancer Survivorship癌症生存者研究

🎓Key Contributions 主要贡献

PRO Methodology in Oncology Trials

Advanced the science of patient-reported outcome measurement in cancer clinical trials, including cognitive function and depression endpoints now used in regulatory submissions.

Cognitive Impairment After Cancer Treatment

Led key studies characterizing cancer-related cognitive impairment (chemobrain) using validated PRO instruments, influencing survivorship care planning.

Distress and Symptom Integration

Developed models integrating distress screening with symptom cluster assessment to provide comprehensive psychosocial profiles for individualized care.

Representative Works 代表性著作

[1]

Patient-Reported Outcomes in Phase III Cancer Clinical Trials: Lessons Learned

Journal of Clinical Oncology (2015)

Outlined best practices for designing, analyzing, and reporting PRO data in phase III trials based on experience with NCI cooperative group studies.

[2]

Cognitive Function and Its Relationship to Other Cancer-Related Symptoms in Patients with Breast Cancer

Psycho-Oncology (2009)

Demonstrated that cognitive complaints co-occur with fatigue, depression, and sleep disturbance, highlighting the need for multisymptom intervention strategies.

[3]

Measuring Depression in Cancer Patients: A PRO Perspective

Journal of the National Cancer Institute Monographs (2007)

Provided regulatory-relevant guidance on selecting and validating depression measures for use as PRO endpoints in oncology clinical trials.

🏆Awards & Recognition 奖项与荣誉

🏆APOS Distinguished Researcher Award
🏆International Society for Quality of Life Research (ISOQOL) Distinguished Researcher Award
🏆Wake Forest University School of Medicine Excellence in Research Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 琳恩·瓦格纳 的研究动态

Follow Lynne I. Wagner's research updates

留下邮箱,当我们发布与 Lynne I. Wagner(Wake Forest University School of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment